Movement Disorders · 2006 · 34 citations · 30 references
MedicineNeurosurgerySurgeryClinical NeuroscienceMovement DisordersNeural EngineeringDeep Brain StimulationNeurodegenerative DiseasesNeurodegenerative DisordersParkinson DiseaseParkinson Disease SurgeryParkinsonian DisordersDeep Brain Stimulation EffectsDisability ReductionHistorical ComparisonInpatient MortalityParkinson’s Disease TreatmentStandardized Mortality RatesStandardized Mortality StatisticsSubthalamic Deep Brain Stimulation
Subthalamic nucleus (STN) stimulation improves motor disability and quality of life in patients with advanced Parkinson's disease (PD). Short-term mortality is low, but little is known about long-term mortality. We assessed mortality and causes of death in 171 consecutive PD patients treated by STN stimulation. Surgery was performed after a median lagtime of 13 years from PD onset at a median age of 57 years. The median follow-up after surgery was 41 months. Sixteen patients died 8 to 83 months after neurosurgery. Poorer cognitive function was the only predictive factor for mortality (standardized mortality ratio = 2.9; 95% confidence interval [CI], 1.6-4.7; P < 0.0001). Based on a historical comparison of 118 operated patients with 39 nonoperated patients from a different population, survival among operated patients was not better (hazard ratio = 1.2; 95% CI, 0.7-2.1).
30
Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology
Alexander Zimprich, Saskia Biskup, Petra Leitner et al. · Neuron · 2004 · 3.1K citations · Full text
Cloning of the Gene Containing Mutations that Cause PARK8-Linked Parkinson's Disease
Coro Paisán-Ruı́z, Shushant Jain, E. Whitney Evans et al. · Neuron · 2004 · 2.4K citations · Full text